Nalaganje...
RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation
Oestrogen receptor ɑ (ERɑ) is overexpressed in two‐thirds of all breast cancers and involves in development and breast cancer progression. Although ERɑ‐positive breast cancer could be effective treated by endocrine therapy, the endocrine resistance is still an urgent clinical problem. Thus, further...
Shranjeno v:
| izdano v: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6111850/ https://ncbi.nlm.nih.gov/pubmed/29974997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13694 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|